Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-25-000092
Filing Date
2025-01-08
Accepted
2025-01-08 16:15:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 17681
2 ex991to13g10022aeon_010825.htm EX-99.1 10502
  Complete submission text file 0000921895-25-000092.txt   29902
Mailing Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724
Business Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724 631-987-0235
BIGGER CAPITAL FUND L P (Filed by) CIK: 0001288478 (see all company filings)

EIN.: 900131165 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92271 | Film No.: 25518706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)